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Induction of xenobiotic-metabolizing enzymes in hepatocytes 
by beta-naphthoflavone: Time-dependent changes in activities, 
protein and mRNA levels
In the present study, time-dependency of the induction ef-
fect of a selective inducer on the activity, protein and 
mRNA levels of cytochromes P450 1A1/2 (CYP1A1/2), 
NAD(P)H:quinone oxidoreductase 1 (NQO1) and glutathi-
one S-transferases (GSTA), in primary culture of rat hepa-
tocytes was tested and evaluated. To show the differences 
in responses of tested enzymes, the common aryl hydrocar-
bon receptor (AhR) ligand agonist, beta-naphthoflavone 
(BNF), was used. Induction of CYP1A1/2 by BNF was de-
tected at all time intervals and at all levels (i.e., mRNA, pro-
tein, enzyme activity). Different responses of NQO1 and 
GSTA upon BNF treatment were observed. Our results 
demonstrate that the responses of different xenobiotic-me-
tabolizing enzymes to the inducer vary in time and depend 
on the measured parameter. For these reasons, an induc-
tion study featuring only one-time interval treatment and/
or one parameter testing could produce misleading infor-
mation.
Keywords: aryl hydrocarbon receptor (AhR), beta-naphtho-
flavone, rat hepatocyte, time dependency, mRNA-protein 
correlation
Our bodies are exposed to many xenobiotics that can change the expression and/or 
activity of xenobiotic-metabolizing enzymes (XMEs), which, in turn, may affect the phar-
macological and toxicological properties of administered drugs. Therefore, knowledge 
about the xenobiotics that modulate XME expression is very important. For this purpose, 
in vivo as well as in vitro studies might be used. Many studies have dealt with the induction 
effect of selected compounds on XMEs in the liver. However, most of these studies are 
limited only to a single time interval (e.g., 1, 2). Therefore, some induction effects could be 
missed if the interval from administration to analysis is too short or too long. The data 
obtained and their interpretation are very important, since the results from such assays 
determine whether drug-drug and/or herb-drug interaction studies need to be carried out. 
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The Food and Drug Administration (3) is about to recommend a single time interval for 
the assessment of enzyme induction to predict potential drug-drug interactions, but such 
a “one-point” approach can be misleading. Responses can vary at different time points and 
the results also depend on the method used for evaluation. In induction studies, the effects 
of tested substances for enzyme expression can be followed up using three parameters: 
enzyme activity, protein level and the corresponding mRNA level, with enzyme activity 
outcome considered the most relevant from pharmacological and/or toxicological points of 
view. However, the determination of enzyme activity is unpopular mainly because of 
material consumption and low specificity of the results. For these reasons, instead of mea-
suring enzyme activity, measurements of mRNA and/or protein level are used more fre-
quently (4).
When the induction effect of a tested xenobiotic for a certain enzyme is studied, great 
discrepancies often appear between the results obtained for activity, protein and/or mRNA 
measurements (1, 4–6). There are many potential reasons for low correlations, e.g., involve-
ment of post-transcriptional regulations, direct influence of xenobiotics on enzyme activ-
ity, or a particular time-delay in response in terms of mRNA and protein level. In a one 
time-point study, the time delay regarding induced changes in mRNA and a correspond-
ing protein seems to be most problematic. Such time-delays could vary among different 
enzymes and thus accurate results cannot be expected from a one-time interval induction 
study or from the measurement of only one or two parameters. To verify this hypothesis, 
we decided to measure induced changes in enzyme activities, protein and mRNA of se-
lected hepatic xenobiotic-metabolizing enzymes at several time intervals.
In order to provide evidence of how different responses can occur upon treatment, we 
have focused on cytochromes P450 1A1/2 (CYP1A1/2), NAD(P)H:quinone dehydrogenase 
1 (NQO1) and glutathione S-transferases A (GSTA), all of which are regulated via the aryl 
hydrocarbon receptor (AhR). AhR is a ligand-activated transcriptional factor that belongs 
to the bHLH-PAS (basic helix-loop-helix/Per-Arnt-Sim) family. AhR resides in the cyto-
plasm as an inactivated complex with chaperone proteins (HSP90, XAP2, p23). When the 
ligand binds to AhR, the whole complex is translocated to the nucleus, where the AhR 
nuclear translocator (ARNT) protein is bound to it. Chaperone proteins are released and 
the AhR/ARNT heterodimer binds to the xenobiotic responsive element (XRE) sequence 
and elevates the expression of target genes. Among the AhR target genes are genes for 
Phase I and II biotransformation enzymes (CYP1A1, CYP1A2, CYP1B1, NQO1, GSTs, UDP-
glucuronosyl transferases 1A1, 1A6, 1A9, 2B35) as well as genes involved in the regulation 
of development, proliferation and differentiation (2, 7). Further, a large number of co-regu-
lators involved in the interaction between enhancers and promoters have been recognized 
(8). Typical AhR ligands are polycyclic aromatic hydrocarbons and halogenated aryl hy-
drocarbons along with numerous dietary plant constituents such as indole alkaloids (8).
The present study was designed to show the time-dependency of response to the in-
ducer, the correlation of the tested parameters (mRNA level, protein level, enzyme activi-
ty) as well as differences between individual xenobiotic-metabolizing enzymes. For our 
study, we have selected β-naphthoflavone (BNF, 5,6-benzoflavone), a synthetic flavonoid 
that belongs to the exogenous ligands of AhR group and is often used as a positive control 
in the evaluation of CYP1A induction (9–11). To achieve our aim, we exposed primary rat 
hepatocytes to BNF and monitored the expression and activity of GSTA, NQO1 and CY-
P1A1/2 at several time intervals.
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S-(5′-adenosyl)-l-methionine (SAM), l-glutathione (GSH), 1-chloro-2,4-dinitroben-
zene (CDNB), menadione and coenzyme NAPDH were obtained from Sigma-Aldrich 
(USA). Fetal bovine serum and streptomycin sulfate were purchased from Invitrogen 
(USA). Bovine serum albumin (BSA) was obtained from Fluka (Switzerland). All other 
chemicals, HPLC or analytical grade, were obtained from Sigma-Aldrich.
Ethical statement
The animal protocols used in this work were evaluated and approved by the Ethics 
Committee of the Ministry of Education, Youth and Sports (Protocol MSMT-24185/2015-11). 
The protocols comply with the Guide for the Care and Use of Laboratory Animals (Protec-
tion of Animals from Cruelty Act No. 246/92, Czech Republic).
Isolation and culture of rat hepatocytes
Hepatocytes were isolated by a two-step collagenase method from female rat liver 
(Rattus norvegicus) (12). Isolated hepatocytes were rewashed three times and mixed with 
culture medium (1:1 mixture of Ham F12 and Williams′ E, supplemented with NaHCO3 
and penicillin/streptomycin). Viability of the hepatocytes was determined by a Trypan 
blue efflux test (accepted viability was 70–100 %).
1 × 106 viable cells in 3 mL of culture medium were placed into a Petri dish (6 cm in di-
ameter) coated with collagen. Fetal calf serum was added to the culture medium (5 %) to 
enhance the attachment of cells. After 4 h of rest, the medium was changed to a medium 
containing 10 µmol L–1 BNF or 0.1 % DMSO as a control. Cultures were maintained at 37 °C 
in a humid air atmosphere with 5 % CO2 for up to 2, 4, 12 and 24  h.
Preparation of subcellular fractions
Cytosolic and microsomal fractions were obtained from the control and influenced 
hepatocytes suspended in 0.1 mol L–1 sodium phosphate buffer (pH 7.4). The cells were 
homogenized using sonication with Sonopuls (Germany). Subcellular fractions were iso-
lated by differential centrifugation of the cell homogenate. Subcellular fractions were 
stored at –80 °C. Protein concentrations in the subcellular fractions were assayed using the 
bicinchoninic acid assay according to the Sigma-Aldrich protocol.
Enzyme assays
Cytosolic glutathione S-transferase (GST) activity was assayed as previously reported 
(13). Enzyme activity was expressed in nmol min–1 mg–1 protein.
NQO1 activity was assayed spectrophotometrically by measuring cytochrome c re-
duction at 550 nm in the presence of NADH and menadione as described by Cullen et al. 
(14) in the cytosolic fraction. The NQO1 activity was calculated from the difference be-
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tween a non-inhibited and a dicumarol inhibited reaction. NQO1 activity was expressed 
in nmol min–1 mg–1 of protein.
The activity of ethoxyresorufin-O-deethylase (EROD, ascribed mainly to CYP1A1, 
partly to CYP1A2) was assayed in a microsomal fraction of treated or untreated hepato-
cytes using fixed wavelength fluorescence detection as described by Burke and Mayer (15), 
with the enzyme activity expressed in pmol min–1 mg–1 of protein.
Western blotting
Microsomal or cytosolic proteins (30 µg in each lane) of hepatocytes were separated 
by SDS-PAGE and subsequently transferred onto nitrocellulose membranes (0.45 µm) us-
ing a Trans-Blot® Turbo™ Transfer System (Bio-Rad, USA). The membranes were blocked 
in 5 % non-fat dry milk/TBS-Tween-20 for 2 h. For the immunodetection of CYP1A1, CY-
P1A2, GSTA and NQO1, the membranes were probed overnight with primary antibodies 
[CYP1A1 – rabbit polyclonal, 1:1000 (Novus Biologicals, USA), CYP1A2 – mouse monoclo-
nal, 1:1000 (Novus Biologicals), GSTA – goat polyclonal, 1:3000 (Abcam, UK), NQO1 – rab-
bit monoclonal, 1:3000 (Novus Biologicals)] diluted in TBS-Tween 20 supplemented with 1 
% BSA, washed four times with TBS-Tween 20 buffer and probed with complementary 
secondary antibodies for 1 h [bovine anti-goat IgG-HRP, 1:3000, Santa Cruz Biotechnology 
(USA), bovine anti-mouse IgG-HRP, 1:10 000, Santa Cruz Biotechnology, bovine anti-rabbit 
IgG-HRP, 1:10 000, Santa Cruz Biotechnology]. The signal was detected using an enhanced 
Amersham ECL chemiluminescence kit (GE Healthcare Life Sciences, USA) according to 
the manufacturer’s instructions. β-actin (mouse monoclonal, 1:3000, Abcam) served as the 
loading control. The intensity of bands was evaluated using a C-DiGit™ Blot Scanner (LI-
COR Biotechnology, USA). Protein levels were measured in two independent experiments.
RNA isolation and quantitative real-time PCR
Total RNA was isolated using TriReagent according to the manufacturer’s instruc-
tions (Molecular Research Center, Inc., USA). RNA concentration and purity were deter-
mined spectrophotometrically. First strand cDNA was synthesized from 1 µg total RNA 
using ProtoScript II reverse transcriptase (New England Biolabs, USA) and random hex-
amers. qPCR analyses were performed in a QuantStudio 6 Flex (Applied Biosystems, USA) 
using a qPCR Core kit for SYBR Green I (Eurogentec, Belgium) following the manufac-
turer’s protocol. Primers were designed manually using Primer3 software (16) for CYP1A1 
and 1A2 one primer set was designed to recognize both isoforms. Primer sequences and 
amplicon sizes are listed in Table I.
Calculations were based on the Delta-Delta Ct method (17), with data expressed as the 
fold change of treatment groups relative to the control. Beta-2 microglobulin (B2M) was 
used as the reference gene, with the gene’s stability verified upon BNF treatment.
Statistical analysis
All calculations were done using Microsoft Excel and GraphPad Prism 6.04. Student’s 
t-test was used for statistical evaluation of the differences between the treated groups and 
controls. p-value < 0.05 was considered statistically significant. All measurements were 
performed in triplicate.
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RESULTS AND DISCUSSION
Time-dependent response of DMEs in the control
In the present in vitro study, primary cultures of rat hepatocytes served as the model 
considered to be the most relevant for predicting in vivo induction (4, 18, 19).
Firstly, we followed up the time-dependent changes of expression levels and activities 
of CYP1A1/2, NQO1 and GSTA in untreated hepatocytes during a 24 hour-cultivation 
(Table II). Great differences between individual enzymes as well as between other tested 
parameters were observed. Twenty-four hours after isolation, the level of CYP1A1/2 mRNA 
had decreased almost to zero, while NQO1 mRNA and GSTA mRNA increased up to 450 
and 200 %, resp. Increase of NQO1 and GSTA expression could have been evoked by in-
creased oxidation stress, since antioxidant-responsive elements (ARE) participate in the 
regulation of both enzymes (20, 21). Relative stability was found for the proteins. The 
amount of CYP1A1 and CYP1A2 proteins decreased only by 30 %, while the amount of 
NQO1 and GSTA proteins increased by approx. 60 %. The low mRNA-protein correlation 
implied the participation of post-transcriptional regulations in NQO1 expression. Surpris-
ingly, the CYP1A1/2 activity had decreased to zero even 12 hours after the isolation of 
hepatocytes. The activity of GSTA remained unchanged during 24 h, while NQO1 activity 
increased by 79 % and correlated well with the increased protein level.
The effect of BNF on DMEs
CYP1A induction by BNF was clearly observed at all time intervals and at all levels. 
mRNA as well as the corresponding protein and enzyme activity increased gradually dur-
Fig. 1. a) The mRNA expression (normalized to B2M), b) protein levels CYP1A1 and c) CYP1A2 (nor-
malized to β-actin), and d) specific activity (pmol min–1 mg–1) of CYP1A1/2 determined in the control 
and in BNF treated (10 µmol L–1) hepatocytes. The bars represent mean ± SD after at least three inde-
pendent measurements. Statistically significant difference vs. control: *p < 0.05, **p < 0.01, ****p < 
0.0001. BNF – beta-naphthoflavone, nd – not detected.
                                                     b)
    a)                                                                                               d)
 
 
                                                     c)
81
K. Lněničková et al.: Induction of xenobiotic-metabolizing enzymes in hepatocytes by beta-naphthoflavone: Time-dependent chang-
es in activities, protein and mRNA levels, Acta Pharm. 68 (2018) 75–85.
 
ing a 24-h exposure of hepatocytes to BNF and all tested parameters correlated well. The 
response to BNF in hepatocytes was in agreement with the observation that the induction 
of hepatic CYP1A1/CYP1A2 mRNA and CYP1A activity in rats in vivo occurred within 2 h 
after BNF administration (22). A good correlation between the induction of CYP1A1/2 
enzyme activities and mRNA expression in human hepatocytes has been also reported (4). 
For example, the plant flavonoid rutin induced the expression of CYP1A1 in a human liver 
cancer cell line even after a 48-h treatment (23). These results explain why CYP1A inducers 
are so easily revealed; any time-interval and any parameter is suitable for a CYP1A induc-
tion study.
On the other hand, NQO1 induction by BNF showed quite different timing, with ex-
pression of mRNA increasing rapidly, reaching a maximum level (16-fold of control) 2 
hours after BNF administration. With increasing duration of exposure, the rate of induc-
tion diminished gradually, with only a 5-fold increase in the mRNA level found after 24-h 
exposure. The amount of NQO1 protein showed an increase after 4 hours, but only up to 
180 % of the control and the level of the protein did not change over the following 20 h. 
Surprisingly, NQO1 activity did not correlate with the amount of NQO1 protein, since it 
rose gradually and reached a 3-fold control level after a 24-h exposure. From the observed 
results, we assume that after two hours the NQO1 mRNA level after BNF administration 
Fig. 2. a) The mRNA expression (normalized to B2M), b) protein levels (normalized to β-actin) and 
c) specific activity (nmol min–1 mg–1) of NQO1 determined in the control and in BNF treated hepato-
cytes. The bars represent mean ± SD after at least three independent measurements. Statistically 
significant difference vs. control: *p < 0.05, ***p < 0.001, ****p < 0.0001. BNF – beta-naphthoflavone.
Fig. 3. a) The mRNA expression (normalized to B2M), b) protein levels (normalized to β-actin) and 
c) specific activity (nmol min–1 mg–1) of GSTA determined in the control and in BNF treated hepato-
cytes. The bars represent mean ± SD after at least three independent measurements. Statistically 
significant difference vs. control: ***p < 0.001, ****p < 0.0001. BNF – beta-naphthoflavone.
a)                                                   b)                                                      c)
a)                                                  b)                                                     c)
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arose to a sufficient amount for higher protein production, which was indeed detected 
after 4-h. The increasing activity throughout our experiment without the corresponding 
protein level increase is hard to explain.
Regulation of GSTs is more complicated, with several mechanisms described (24). 
Nevertheless, the presence of XRE elements in the promotor region of many GSTs (namely, 
the GSTA family) was shown and the increase of hepatic GSTA after the administration of 
BNF to rats or mice was reported (8, 24, 25). However, in our study, BNF increased GSTA 
mRNA only after a 2-h exposure and GSTA protein only after a 24-h exposure, which is a 
surprisingly long time span between mRNA and protein response. At all other time-
points, the mRNA level as well as protein level seemed to be unaffected. Moreover, GST 
activity decreased after BNF exposure at all time intervals, probably due to BNF-mediated 
enzyme inhibition. Flavonoids are potent GST inhibitors (26) and the inhibitory effect of 
residual test compounds in the hepatocyte monolayer can influence the results of activity 
measurement (9).
All the above-mentioned results clearly demonstrate that using only a one-time point 
induction study can render misleading information. When expressions of AhR dependent 
genes after a 24-h treatment with 100 µmol L–1 BNF were compared in various human la-
ryngeal squamous carcinoma cell lines and in the hepatic carcinoma cell line, a massive 
increase of CYP1A1/2 mRNA and a slight or no increase of NQO1 mRNA were observed 
(27). If shorter treatments were used, the NQO1 mRNA increase would be more pro-
nounced, and vice versa, namely, when levels of NQO1 and CYP1A1 mRNA in rat liver were 
measured following BNF i.p. administration, a significant increase of NQO1 mRNA (10-
fold) and CYP1A1 mRNA (800-fold) was observed after an 8-h treatment. However, after 
a 24-h treatment, NQO1 mRNA levels had not changed significantly (28). If only a 24-hour 
treatment was applied, NQO1 induction was not detected. In our study, only a 2-hour ex-
posure of hepatocytes to BNF led to a significant increase in the mRNA of all tested en-
zymes. When longer exposure is applied, there is a growing risk of degradation of the in-
duced mRNA.
In general, the correlation between mRNA and protein abundance is strongly affected 
by many factors and a high correlation cannot be assumed (29). Comparing the tested 
parameters, the quantification of mRNA is the most specific and precise parameter, but it 
can serve only for the evaluation of a transcriptional response to the tested compounds 
and has only a low predictive value from a pharmacological and/or toxicological point of 
view. On the other hand, enzyme activity testing has a greater potential to reveal drug-
drug interaction, but it is much less specific.
CONCLUSIONS
Taken together, when the effect of the potential inducer is studied only at a one-time 
point, the induction effect can be underestimated and some valuable information can be 
lost. Our results showed that only some enzymes (e.g., CYP1A1/2) have a good correlation 
between enzyme activity, protein and mRNA level in response to inducers. In conclusion, 
protein quantification seems to bring the most valuable results, as it has good specificity 
and protein levels are relatively stable. Certainly, concomitant testing of at least two pa-
rameters is better for a more accurate interpretation of the induction study results.
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